This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Bristol-Myers Squibb Company
Drug Names(s): TGR5 agonist
Description: XL475 is a TGR5 agonist.
Deal Structure: The program was outlicensed to Bristol Myers Squibb in October 2010.
Partners: Exelixis, Inc.
Additional information available to subscribers only: